Discontinuation of Methotrexate or TNF Inhibitors in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis

被引:0
|
作者
George, Michael D. [1 ]
Baker, Joshua F. [2 ,3 ]
Ogdie, Alexis [4 ]
机构
[1] Univ Penn, Div Rheumatol, Philadelphia, PA 19104 USA
[2] Philadelphia VA Med Ctr, Philadelphia, PA USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Univ Penn, Med Rheumatol & Epidemiol, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
698
引用
收藏
页数:2
相关论文
共 50 条
  • [41] GOLIMUMAB UTILIZATION PATTERNS AND REFILL ADHERENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Ellis, L.
    Bolge, S.
    Rice, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1154 - 1154
  • [42] COMPARATIVE DRUG SURVIVAL OF TNF INHIBITORS AND SECUKINUMAB IN BIOLOGIC NAIVE PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS
    Cheila, M.
    Douglas, K.
    Koutsianas, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 723 - 724
  • [44] Patient adherence to TNFα inhibitors in rheumatoid arthritis and psoriatic arthritis
    Oskarsdottir, Thorunn
    Gunnarsdottir, Anna Ingibjorg
    Gudbjornsson, Bjorn
    Gunnarsson, Petur Sigurdur
    Love, Thorvardur
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 182 - 182
  • [45] Time to Discontinuation of Tofacitinib and TNF Inhibitors in Rheumatoid Arthritis Patients with and Without Methotrexate: Real World Results from a Rheumatoid Arthritis Cohort
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Keystone, Edward C.
    Bombardier, Claire
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [46] Perspectives on Treatment Burden for Methotrexate and TNF-inhibitors Among Psoriatic Arthritis and Rheumatoid Arthritis Patients: A Qualitative Study
    Ogdie, Alexis
    Shaw, Yomei
    Almonte, Michele
    Maksabedian, Ervant
    Michaud, Kaleb
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [47] PREVALANCE OF HIP ARTHRITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH TNF INHIBITORS
    Konsta, M.
    Nurmohamed, M. T.
    van denderen, J. C.
    Visman, I
    van der Horst-Bruinsma, I. E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 775 - 775
  • [48] Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
    Cantini, Fabrizio
    Nannini, Carlotta
    Niccoli, Laura
    Petrone, Linda
    Ippolito, Giuseppe
    Goletti, Delia
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [49] LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS
    Shaw, Tim
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin
    Nash, Peter
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana Paula
    Pierre-Louis, Bosny J.
    Mease, Philip J.
    RHEUMATOLOGY, 2022, 61
  • [50] LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS
    Nash, Peter
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana P.
    Pierre-Louis, Bosny J.
    Shaw, Tim
    Mease, Philip J.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 27 - 27